Literature DB >> 16285003

Evaluation of the nuclear delivery and intra-nuclear transcription of plasmid DNA condensed with micro (mu) and NLS-micro by cytoplasmic and nuclear microinjection: a comparative study with poly-L-lysine.

Hidetaka Akita1, Mitsuhide Tanimoto, Tomoya Masuda, Kentaro Kogure, Susumu Hama, Keiko Ninomiya, Shiroh Futaki, Hideyoshi Harashima.   

Abstract

BACKGROUND: The efficient nuclear delivery of plasmid DNA (pDNA) is essential for the development of a promising non-viral gene vector. In an attempt to achieve nuclear delivery, NLS-mu, a novel pDNA condenser, was prepared. This consists of mu, a highly potent polypeptide for condensing the pDNA, and a SV40 T antigen-derived nuclear localization signal (NLS(SV40)).
METHODS: The utility of NLS-mu was assessed in terms of green fluorescent protein (GFP) expression after cytoplasmic and nuclear microinjection of GFP-encoding pDNA along with the transfection, and compared with mu and poly-L-lysine (PLL). Trans-gene expression after cytoplasmic microinjection was affected by the efficiencies of nuclear transfer and following intra-nuclear transcription. To evaluate the nuclear transfer process separately, we introduced a parameter, a nuclear transfer score (NT score), which was calculated as the trans-gene expression after cytoplasmic microinjection divided by that after nuclear microinjection.
RESULTS: As expected, the rank order of trans-gene expression after the transfection and cytoplasmic microinjection was NLS-mu > mu > PLL. However, the calculated NT scores were unexpectedly ranked as mu = NLS-mu > PLL, suggesting that mu, and not NLS(SV40), is responsible for the nuclear delivery of pDNA. In addition, confocal images of rhodamine-labeled pDNA indicated that pDNA condensed with mu and NLS-mu was delivered as a condensed form. In comparing the nuclear transcription, the rank order of trans-gene expression after nuclear microinjection was PLL = NLS-mu > mu, suggesting that intra-nuclear transcription is inhibited by efficient condensation by mu, and is avoided by the attachment of NLS(SV40).
CONCLUSIONS: Collectively, NLS-mu, which consists of chimeric functions, is an excellent DNA condenser, and the process is based on mu-derived nuclear transfer and NLS(SV40)-derived efficient intra-nuclear transcription. Copyright 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16285003     DOI: 10.1002/jgm.839

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  5 in total

1.  Quantitative comparison between poly(L-arginine) and poly(L-lysine) at each step of polyplex-based gene transfection using a microinjection technique.

Authors:  Tomoko Hashimoto; Takeshi Kawazu; Takeshi Nagasaki; Akira Murakami; Tetsuji Yamaoka
Journal:  Sci Technol Adv Mater       Date:  2012-02-09       Impact factor: 8.090

2.  Peptide-mediated lipofection is governed by lipoplex physical properties and the density of surface-displayed amines.

Authors:  Jennifer C Rea; Annelise E Barron; Lonnie D Shea
Journal:  J Pharm Sci       Date:  2008-11       Impact factor: 3.534

3.  Effect of the Compaction and the Size of DNA on the Nuclear Transfer Efficiency after Microinjection in Synchronized Cells.

Authors:  Hidetaka Akita; Dai Kurihara; Marco Schmeer; Martin Schleef; Hideyoshi Harashima
Journal:  Pharmaceutics       Date:  2015-06-09       Impact factor: 6.321

4.  Peptide dendrimer/lipid hybrid systems are efficient DNA transfection reagents: structure--activity relationships highlight the role of charge distribution across dendrimer generations.

Authors:  Albert Kwok; Gabriela A Eggimann; Jean-Louis Reymond; Tamis Darbre; Florian Hollfelder
Journal:  ACS Nano       Date:  2013-05-17       Impact factor: 15.881

5.  Quantitative and mechanism-based investigation of post-nuclear delivery events between adenovirus and lipoplex.

Authors:  Susumu Hama; Hidetaka Akita; Shinya Iida; Hiroyuki Mizuguchi; Hideyoshi Harashima
Journal:  Nucleic Acids Res       Date:  2007-02-07       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.